Market Overview - The Shanghai Composite Index rose by 1.19% on December 17, with 28 out of 33 sectors experiencing gains, led by the communication and non-ferrous metals sectors, which increased by 5.07% and 3.03% respectively [1] - The agriculture, forestry, animal husbandry, and fishery sector had the largest decline, falling by 0.54% [1] Capital Flow Analysis - The net inflow of capital in the two markets was 9.51 billion yuan, with 16 sectors seeing net inflows [1] - The communication sector had the highest net inflow of 6.45 billion yuan, coinciding with its 5.07% increase [1] - The electronics sector also saw a significant net inflow of 6.34 billion yuan, with a daily increase of 2.48% [1] Agriculture, Forestry, Animal Husbandry, and Fishery Sector - This sector experienced a decline of 0.54%, with a net outflow of 1.94 billion yuan [2] - Out of 105 stocks in this sector, 60 rose, while 39 fell, including 3 that hit the daily limit down [2] - The top three stocks with the highest net inflow were COFCO Sugar Industry (35.26 million yuan), Beidahuang (33.62 million yuan), and Muyuan Foods (31.82 million yuan) [2] Capital Outflow in Agriculture, Forestry, Animal Husbandry, and Fishery Sector - The top three stocks with the highest net outflow were Pingtan Development (-1.28 billion yuan), Luoniushan (-264.82 million yuan), and Biological Shares (-142.17 million yuan) [4] - Pingtan Development saw a significant drop of 10.03%, while Luoniushan and Biological Shares fell by 9.19% and 10.01% respectively [4]

证券之星消息，12月17日动物保健板块较上一交易日下跌2.24%，生物股份领跌。当日上证指数报收于 3870.28，上涨1.19%。深证成指报收于13224.51，上涨2.4%。动物保健板块个股涨跌见下表： 从资金流向上来看，当日动物保健板块主力资金净流出1.42亿元，游资资金净流入3867.16万元，散户资 金净流入1.03亿元。动物保健板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 ...

从资金流向上来看，当日动物保健板块主力资金净流出1512.58万元，游资资金净流出0.88万元，散户资 金净流入1513.46万元。动物保健板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月16日动物保健板块较上一交易日上涨1.06%，生物股份领涨。当日上证指数报收于 3824.81，下跌1.11%。深证成指报收于12914.67，下跌1.51%。动物保健板块个股涨跌见下表： ...

Group 1 - The core viewpoint of the article is that the company, BioShares (600201.SH), has confirmed that both its rabies vaccine and cat trivalent vaccine are currently on sale [1] - The cat trivalent vaccine has seen significant sales growth in the first three quarters, facilitated by a combination of online and offline sales strategies [1]

Group 1 - The core viewpoint of the article is that the company, Shengwu Co., Ltd. (600201.SH), has confirmed that both its rabies vaccine and cat trivalent vaccine are currently on sale [1] - The cat trivalent vaccine has seen significant sales growth in the first three quarters, attributed to the integration of online and offline sales channels [1]

Core Viewpoint - Junshi Biosciences has submitted its listing application to the Hong Kong Stock Exchange, focusing on innovative cell therapies and drug development for solid tumors, with its core product GC101 expected to be the first approved tumor-infiltrating lymphocyte (TIL) therapy [1][2]. Financial Performance - The company is projected to incur net losses of approximately RMB 94 million, RMB 164 million, and RMB 98 million for the years 2023, 2024, and the first half of 2025, respectively [3][4]. - Research and development costs are expected to be RMB 57.62 million, RMB 90.99 million, and RMB 52.80 million for the years 2023, 2024, and the first half of 2025, respectively [5]. Product Development - GC101 is currently undergoing a key Phase II clinical trial for melanoma and is expected to submit a Biologics License Application (BLA) by 2026. Additionally, it is in Phase Ib for non-small cell lung cancer [2]. - The company has established a TIL production base in China, utilizing high-standard production equipment and a digital management platform to ensure scalable preparation and reliable delivery of TIL cell products [2]. Fundraising Purpose - The funds raised from the listing are intended to advance the clinical development of TIL product pipelines, upgrade the company's technology platform, enhance production management and manufacturing capabilities, and support working capital and other general corporate purposes [2].

Core Viewpoint - Luye Pharma Group Limited has completed the issuance of 1.5 million exchangeable preferred shares, which can be exchanged for existing shares of Boan Biotechnology, representing approximately 16.15% of Boan's total issued shares [1] Group 1 - The issuer, Luye Geneora Holding Limited, a wholly-owned subsidiary of the company, has allocated and issued 1.5 million exchangeable preferred shares to the subscribers [1] - The exchangeable preferred shares can be converted into shares of Boan Biotechnology without the issuance of any new shares by Boan [1] - Based on the initial exchange price of HKD 11.718, the total number of Boan shares deliverable upon the exchange of all preferred shares is up to 100,486,431 shares [1]

从资金流向上来看，当日动物保健板块主力资金净流出7682.64万元，游资资金净流出3965.3万元，散户 资金净流入1.16亿元。动物保健板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月12日动物保健板块较上一交易日上涨1.82%，生物股份领涨。当日上证指数报收于 3889.35，上涨0.41%。深证成指报收于13258.33，上涨0.84%。动物保健板块个股涨跌见下表： ...

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][51]. Core Insights - Recent recovery in pig prices is noted, with expectations for continued price increases as the seasonal consumption peak approaches. The inventory of breeding sows remains relatively high, indicating significant potential for capacity reduction [51]. - The report highlights investment opportunities in leading pig farming companies due to expected capacity reduction and improving profitability margins in chicken farming [51]. - The report emphasizes the importance of strong R&D capabilities in animal health companies and the long-term growth potential of domestic pet food leaders [51]. Industry Performance Overview - The SW agriculture, forestry, animal husbandry, and fishery industry underperformed the CSI 300 index, declining by 0.92% from November 28 to December 11, 2025, lagging behind the index by approximately 1.73 percentage points [12]. - Among the sub-sectors, only animal health and planting recorded positive returns, increasing by 1.96% and 1.18%, respectively, while other sectors such as agricultural product processing, feed, breeding, and fishery experienced declines of 1.01%, 1.5%, 3.03%, and 3.76% [15][18]. - Approximately 68% of stocks in the industry recorded negative returns during the same period, with over 60% of stocks showing losses [16][18]. Valuation Metrics - As of December 11, 2025, the overall price-to-book (PB) ratio for the SW agriculture, forestry, animal husbandry, and fishery industry is approximately 2.75 times, reflecting a recent decline in valuation. This level is around 61.8% of the historical median since 2006, indicating a relatively low historical valuation [19]. Key Industry Data - **Pig Farming**: The average price of external three yuan pigs rose from 11.28 CNY/kg to 11.45 CNY/kg during the reporting period. However, self-breeding pig farming continues to incur losses, with profits at -163.34 CNY per head, while purchased pig farming shows a loss of -240.69 CNY per head [23][28]. - **Poultry Farming**: The average price of broiler chicks increased slightly to 3.54 CNY per chick, while the average price of white feather broilers rose to 7.33 CNY/kg, with losses of -0.71 CNY per bird [30][33]. Company Highlights - The report suggests focusing on key companies such as Muyuan Foods (002714), Wens Foodstuff Group (300498), and Shengnong Development (002299) due to their market leadership and potential for recovery [51][52].

Group 1 - The China Livestock Breeding Index (930707) increased by 0.44% as of December 12, 2025, with notable gains in constituent stocks such as Luo Niu Shan (000735) up 6.21%, and BioShares (600201) up 2.99% [1] - The Central Reserve Frozen Pork Rotation Storage Auction will take place on December 18, 2025, with 3,100 tons available for bidding, as announced by the China Storage Network [1] - Recent analysis indicates that traditional peak season for pork consumption is leading to a steady recovery in demand, driven by colder weather and increased demand for cured meats in southern regions, although supply remains high due to previous production capacity [1] Group 2 - As of November 28, 2025, the top ten weighted stocks in the China Livestock Breeding Index account for 65.6% of the index, including Muyuan Foods (002714) and Wens Foodstuff Group (300498) [2] - The index reflects the overall performance of listed companies involved in livestock feed, veterinary drugs, and livestock farming [1]